1. Home
  2. FULC vs SGU Comparison

FULC vs SGU Comparison

Compare FULC & SGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$6.17

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

SGU

Star Group L.P.

HOLD

Current Price

$12.90

Market Cap

410.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
SGU
Founded
2015
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
467.8M
410.0M
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
FULC
SGU
Price
$6.17
$12.90
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$16.38
N/A
AVG Volume (30 Days)
586.4K
22.9K
Earning Date
04-27-2026
05-11-2026
Dividend Yield
N/A
5.90%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,784,418,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.70
Revenue Growth
N/A
1.04
52 Week Low
$5.90
$11.31
52 Week High
$15.74
$13.53

Technical Indicators

Market Signals
Indicator
FULC
SGU
Relative Strength Index (RSI) 31.50 53.53
Support Level N/A $12.31
Resistance Level $7.09 $12.99
Average True Range (ATR) 0.41 0.35
MACD -0.07 0.00
Stochastic Oscillator 0.00 53.91

Price Performance

Historical Comparison
FULC
SGU

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About SGU Star Group L.P.

Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.

Share on Social Networks: